{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:05Z","timestamp":1791979085019,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002733"],"award-info":[{"award-number":["UL1TR002733"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11697-6","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:34Z","timestamp":1761042394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Daptomycin versus beta-lactam based therapy for the treatment of enterococcal endocarditis and other endovascular infections: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Vindya","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Wardlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Sobhanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelci","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Leininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"11697_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial Therapy, and management of complications: A scientific statement for healthcare professionals from the American heart association. Circulation. 2015;132:1435\u201386. https:\/\/doi.org\/10.1161\/CIR.0000000000000296.","journal-title":"Circulation"},{"key":"11697_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","volume":"26","author":"J Turnidge","year":"2020","unstructured":"Turnidge J, Kahlmeter G, Cant\u00f3n, et al. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: A EUCAST position paper. Clin Microbiol Infect. 2020;26:1039\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.027.","journal-title":"Clin Microbiol Infect"},{"key":"11697_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40121-015-0072-z","volume":"4","author":"C L\u00fcbbert","year":"2015","unstructured":"L\u00fcbbert C, Rodloff AC, Hamed K. Real-World treatment of enterococcal infections with daptomycin: insights from a large European registry (EU-CORE). Infect Dis Ther. 2015;4:259\u201371. https:\/\/doi.org\/10.1007\/s40121-015-0072-z.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"11697_CR4","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1128\/aac.01563-13","volume":"57","author":"M Carugati","year":"2013","unstructured":"Carugati M, Bayer AS, Mir\u00f3 JM, et al. High-Dose daptomycin therapy for Left-Sided infective endocarditis: A prospective study from the international collaboration on endocarditis. Antimicro Agents Chemo. 2013;57(12):6213\u201322. https:\/\/doi.org\/10.1128\/aac.01563-13.","journal-title":"Antimicro Agents Chemo"},{"key":"11697_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/jac\/dku004","volume":"69","author":"I Cer\u00f3n","year":"2014","unstructured":"Cer\u00f3n I, Mu\u00f1oz P, Mar\u00edn M, et al. Efficacy of daptomycin in the treatment of enterococcal endocarditis: A 5-Year comparison with conventional therapy. J Antimicrob Chemother. 2014;69:1669\u201374. https:\/\/doi.org\/10.1093\/jac\/dku004.","journal-title":"J Antimicrob Chemother"},{"key":"11697_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40121-019-00261-w","volume":"8","author":"M Peghin","year":"2019","unstructured":"Peghin M, Russo A, Givone F, et al. Should High-Dose daptomycin be an alternative treatment regimen for enterococcal endocarditis? Infect Dis Ther. 2019;8:695\u2013702. https:\/\/doi.org\/10.1007\/s40121-019-00261-w.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"11697_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) \u2013 A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"key":"11697_CR8","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software partners. J Biomed Inf. 2019 May;9. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"issue":"2","key":"11697_CR9","first-page":"200","volume":"13","author":"G Romano","year":"2004","unstructured":"Romano G, Carozza A, Della Corte A, et al. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcomes in 353 patients. J Heart Valve Dis. 2004;13(2):200\u20138.","journal-title":"J Heart Valve Dis"},{"key":"11697_CR10","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","volume":"40","author":"G Habib","year":"2019","unstructured":"Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehz620.","journal-title":"Eur Heart J"},{"key":"11697_CR11","doi-asserted-by":"publisher","unstructured":"Garcia-Solache M, Rice LB. The enterococcus: a model of adaptability to its environment. Clin Microbiol Rev. 2019;32(2). https:\/\/doi.org\/10.1128\/cmr.00058-18. 10.1128\/cmr.00058\u2009\u2013\u200918.","DOI":"10.1128\/cmr.00058-18"},{"issue":"8","key":"11697_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cix024","volume":"64","author":"YC Chuang","year":"2017","unstructured":"Chuang YC, Lin HY, Chen PY, et al. Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis. 2017;64(8):1026\u201334. https:\/\/doi.org\/10.1093\/cid\/cix024.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11697-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:04:46Z","timestamp":1761087886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11697-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11697"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11697-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the Declaration of Helsinki and approved by the Ohio State Biomedical Sciences Institutional Review Board (study 2023H0348) with a waiver of informed consent granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1361"}}